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1 |  INTRODUCTION
Mesial temporal lobe (MTL) resection or ablation (from herein 
referred to as “MTL resection”) can eliminate seizures in many 
patients with unilateral MTL seizures.1‒3 However, if seizures 
arise bilaterally, achieving seizure remission is unlikely be-
cause bilateral MTL resection is not an option due to high risk 
of severe anterograde memory loss.4 Unilateral MTL resection 
in a patient with bilateral independent MTL onset can provide 
substantial palliation in carefully selected patients. However, it 
may not be possible to establish a confident estimate of MTL 
seizure lateralization within 1-2  weeks of inpatient video–
electroencephalography (EEG) monitoring. In a group of 82 
patients treated with the RNS System with bilateral MTL leads 
and confirmed bilateral MTL seizures, the average time to 
record the first contralateral MTL electrographic seizure was 
41.6 days,5 considerably longer than the average length of typi-
cal epilepsy monitoring unit (EMU) inpatient stays.6 In addi-
tion, some patients cluster from alternate sides, with most or 
all seizures arising from one side for weeks to months, only to 
switch to the other side at other times.7 In addition to the short 
time window permissible with typical scalp or intracranial re-
cordings in the EMU, withdrawal of antiseizure medications, 
sleep deprivation, anesthesia, stress, and the postoperative set-
ting could alter normal patterns of seizures and even trigger 
seizures that otherwise would not occur.8‒11 Thus, limitations 
Abstract
Objective: To describe seizure outcomes in patients with medically refractory epi-
lepsy who had evidence of bilateral mesial temporal lobe (MTL) seizure onsets and 
underwent MTL resection based on chronic ambulatory intracranial EEG (ICEEG) 
data from a direct brain-responsive neurostimulator (RNS) system.
Methods: We retrospectively identified all patients at 17 epilepsy centers with MTL 
epilepsy who were treated with the RNS System using bilateral MTL leads, and in 
whom an MTL resection was subsequently performed. Presumed lateralization based 
on routine presurgical approaches was compared to lateralization determined by RNS 
System chronic ambulatory ICEEG recordings. The primary outcome was frequency 
of disabling seizures at last 3-month follow-up after MTL resection compared to sei-
zure frequency 3 months before MTL resection.
Results: We identified 157 patients treated with the RNS System with bilateral MTL 
leads due to presumed bitemporal epilepsy. Twenty-five patients (16%) subsequently 
had an MTL resection informed by chronic ambulatory ICEEG (mean = 42 months 
ICEEG); follow-up was available for 24 patients. After MTL resection, the median 
reduction in disabling seizures at last follow-up was 100% (mean: 94%; range: 50%-
100%). Nine patients (38%) had exclusively unilateral electrographic seizures recorded 
by chronic ambulatory ICEEG and all were seizure-free at last follow-up after MTL 
resection; eight of nine continued RNS System treatment. Fifteen patients (62%) had 
bilateral MTL electrographic seizures, had an MTL resection on the more active side, 
continued RNS System treatment, and achieved a median clinical seizure reduction of 
100% (mean: 90%; range: 50%-100%) at last follow-up, with eight of fifteen seizure-free. 
For those with more than 1 year of follow-up (N = 21), 15 patients (71%) were seizure-
free during the most recent year, including all eight patients with unilateral onsets and 7 
of 13 patients (54%) with bilateral onsets.
Significance: Chronic ambulatory ICEEG data provide information about lateralization of 
MTL seizures and can identify additional patients who may benefit from MTL resection.
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in the data provided by the typical presurgical evaluation may 
lead to a faulty conclusion about a patient's laterality, espe-
cially in patients with possible bitemporal epilepsy.
The study's intent was threefold: (a) to evaluate how in-
formation provided by chronic ambulatory intracranial EEG 
(ICEEG) monitoring data captured by the RNS System con-
tributed to the decision to proceed with an MTL resection; (b) 
to determine clinical outcome after MTL resection as assessed 
by reduction in frequency of patient-reported disabling sei-
zures; and (c) to assess how many of these patients continued 
to be treated with the RNS System after MTL resection.
2 |  METHODS
A retrospective chart review was conducted at 17 compre-
hensive epilepsy centers of all patients with medically in-
tractable focal-onset seizures who were treated with the RNS 
System between 2006 and 2016 using bilateral hippocampal 
depth or subtemporal cortical strip leads, and in whom an 
MTL resection was subsequently performed.
The RNS System (NeuroPace, Inc) is approved by the 
US Food and Drug Administration (FDA) as an adjunc-
tive treatment for adults with refractory focal-onset epi-
lepsy having one or two seizure foci. Safety and efficacy 
were demonstrated in a randomized controlled trial and 
in a long-term open-label follow-up study.12,13 The RNS 
System includes a cranially implanted neurostimulator that 
is connected to one or two depth or cortical strip leads, 
each containing four electrode contacts. The leads are 
placed at that patient's seizure focus/foci (Figure 1). The 
neurostimulator continuously monitors ICEEG activity, 
and when patient-specific abnormal patterns are detected, 
stimulation is automatically delivered. In addition, the neu-
rostimulator provides continuous counts of pattern detec-
tions, data regarding the time and location of detections, 
recordings during pattern detections, as well as scheduled 
brief recordings of ICEEG activity.
2.1 | Clinical outcomes
Data obtained from patients’ medical records included demo-
graphics (age, age at epilepsy onset, and etiology), results of 
presurgical localization studies (scalp and intracranial EEG, 
and neuroimaging), EEG lateralization of seizures before 
RNS System treatment, type and location of leads connected 
to the neurostimulator, electrographic seizure lateralization 
with RNS System chronic ambulatory ICEEG, and type of 
MTL resection performed. Patient-reported frequency of 
disabling seizures (focal aware motor, focal with impaired 
awareness, focal to bilateral tonic-clonic), number of antisei-
zure medications, and driving status were determined for the 
3 months before RNS System treatment, the 3 months before 
MTL resection, and at the most recent follow-up. The pri-
mary outcome measure was seizure frequency at the most 
recent follow-up compared to the 3 months before MTL re-
section. Seizure frequency was determined by medical record 
Key Points
• Chronic intracranial EEG (ICEEG) data obtained by 
the RNS System may identify candidates for curative 
or palliative mesial temporal lobe (MTL) resections
• Twenty-five of 157 patients (16%) treated with the 
RNS System with bilateral MTL leads had a re-
section based on chronic ambulatory ICEEG data
• All nine patients with only unilateral electro-
graphic seizures were seizure-free after MTL re-
section; eight continued RNS System treatment
• All 15 patients with bilateral-onset seizures treated 
with MTL resection and RNS System had ≥50% 
seizure reduction; 8 of 15 were seizure-free
• In carefully selected patients with presumed 
bitemporal epilepsy, MTL resection informed by 
chronic ICEEG may yield excellent outcomes
F I G U R E  1  A, Neurostimulator 
connected to longitudinal bilateral 
hippocampal depth leads (most common 
mesial temporal lobe [MTL] treatment 
configuration). B, Neurostimulator 
connected to bilateral subtemporal strip 
leads
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review, including any information available in the record as 
part of clinical care (clinician notes, patient diaries, patient 
questionnaires, and so on). In addition, all treating physicians 
completed a Clinical Global Impression Scale (CGIS) to as-
sess the physician's subjective opinion of patient outcome 
after MTL resection. Adverse events attributed to the neuro-
stimulator or MTL resection were identified based on chart 
review.
2.2 | Chronic intracranial EEG review
RNS System chronic ambulatory ICEEG recordings were 
reviewed on the NeuroPace Patient Data Management 
System (PDMS), a secure online interface, in order to 
determine lateralization of MTL electrographic sei-
zures. An electrographic seizure was defined as “a sus-
tained rhythmic discharge, including repetitive spiking 
or spike-and-wave pattern faster than or equal to 2  Hz, 
with definite evolution in frequency, location, or mor-
phology, and clearly distinguishable from background, 
lasting at least 10  seconds in duration.”14 The chronic 
ambulatory ICEEG review was performed pre-MTL re-
section and post-MTL resection through most recent 
follow-up for patients who continued to be monitored 
with the RNS System. The final lateralization of electro-
graphic seizures was determined by the patient's treating 
neurologist.
T A B L E  1  Patient characteristics based on lateralization with long-term ICEEG monitoring
 
Unilateral electrographic MTL seizures 
on chronic ambulatory ICEEG 
(N = 9)
Bilateral electrographic MTL seizures 
on chronic ambulatory ICEEG 
(N = 15)
Age (y) Mean: 46
(median: 42, range: 31-67)
Mean: 40
(median: 36, range: 19-61)
Duration of epilepsy (y) Mean: 18
(median: 13, range: 8-50)
Mean: 20
(median: 13, range: 2-46)
Etiology
Unknown 6 (67%) 7 (47%)
Autoimmune epilepsy 1 (11%) 2 (13%)
Head trauma 1 (11%) 1 (7%)
Encephalitis 0 3 (20%)
Hypoxic injury 1 (11%) 0
Other 0 2 (13%)
MTL abnormality detected on MRI
None 1 (11%) 3 (20%)
Unilateral 2 (22%) 7 (47%)
Bilateral 6 (67%) 5 (33%)
EEG monitoring with intracranial electrodes prior to RNS System
Yes 4 (44%) 8 (53%)
No 5 (56%) 7 (47%)
MTL seizure lateralization prior to RNS System
Bilateral 4 (44%) 15 (100%)
Unilateral 4 (44%) 0
Unclear 1 (11%) 0
Duration of treatment with RNS System prior to 
MTL resection  (mo)
Mean: 48
(median: 24, range: 8-115)
Mean: 38
(median: 22, range: 10-117)
Surgical procedure
Anteromesial temporal lobectomy (AMTL) 8 (89%) 14 (93%)
Selective Amygdalohippocampectomy (SAH) 1 (11%) 1 (7%)
Follow-up post-MTL resection  (mo) Mean: 29
(median: 18, range: 11-67)
Mean: 38
(median: 21, range: 6-111)
Abbreviations: ICEEG, intracranial EEG; MTL, mesial temporal lobe.
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3 |  RESULTS
Twenty-five of 157 patients (16%) treated with direct brain-re-
sponsive neurostimulation using bilateral MTL leads underwent 
a subsequent MTL resection. One patient transferred institutions 
and is not included in the analyses. Demographic characteristics 
for the 24 patients with follow-up are presented in Table 1.
3.1 | Presurgical localization and RNS 
System lead placement
Nineteen of the 24 patients had bilateral MTL electrographic 
seizures recorded during presurgical localization (inpatient 
scalp EEG, intracranial EEG, or both). The remaining five pa-
tients had data suggesting bilateral MTL seizures: one had un-
clear lateralization of electrographic seizures, one had bilateral 
mesial temporal sclerosis (MTS), one had good memory and 
language on the side of seizure onset and some seizures that 
were not well lateralized, one had bilateral interictal spikes and 
fast seizure spread contralaterally, and one had bilateral spikes 
and declined a right MTL resection in favor of neurostimulation. 
As a result, all patients underwent bilateral MTL lead placement 
for RNS System treatment. Twenty-two patients had bilateral 
longitudinal hippocampal depth leads (inserted along the long 
axis of the hippocampus with a posterior approach), one patient 
had bilateral orthogonal hippocampal depth leads (implanted 
perpendicular to the long axis of the hippocampus from a lateral 
approach), and one patient had bilateral subtemporal strip leads.
3.2 | Seizure reductions with direct brain-
responsive neurostimulation
Prior to RNS System treatment, the average number of disabling 
seizures per month was 21.2 (range: 2-150). Patients were treated 
with the RNS System for an average of 42  months (median: 
24  months, range: 8-117  months) before MTL resection. The 
median percent reduction in frequency of disabling clinical sei-
zures during the last 3 months of follow-up prior to MTL resec-
tion was 37%, with a responder rate (≥50% reduction) of 54%.
3.3 | Lateralization after chronic 
ambulatory ICEEG
Based on RNS System chronic ambulatory ICEEG, 9 of the 
24 patients (38%) had exclusively unilateral electrographic 
MTL seizures recorded, 4 exclusively from the left and 5 
from the right. The remaining 15 patients (62%) had electro-
graphic seizures recorded bilaterally. However, 13 of 15 had 
more than 90% of their electrographic seizures coming from 
one side. Five patients had electrographic seizures arising 
predominantly from the left (mean: 92.4%, range: 90%-97%) 
and 10 patients predominantly from the right (mean: 87.6%, 
range: 60%-96%). In all cases, surgery was performed on the 
MTL with the majority of electrographic seizures.
3.4 | MTL surgeries and outcomes
Twenty-two of the 24 patients had an anteromesial temporal lobec-
tomy (AMTL) and two had a selective amygdalohippocampec-
tomy (SAH). No patient underwent laser ablation. Fifteen surgeries 
(62%) were right and nine surgeries (38%) were left.
Twenty-three of the 24 patients continued to be treated 
with the RNS System post-MTL resection (monitored and 
receiving brain-responsive neurostimulation). Seventeen of 
these 23 patients were monitored with the RNS System bilat-
erally by either adding or newly connecting an existing cor-
tical strip lead on the resected side (N = 8) or, as shown in 
Figure 2, by pulling back the depth lead on the resected side 
(N = 9). Six of the 23 patients continued to be monitored with 
the RNS System only in the temporal lobe contralateral to the 
MTL resection. One patient had the neurostimulator and leads 
explanted at the time of resection (Table 2).
F I G U R E  2  Illustration of bilateral hippocampal depth leads 
connected to the neurostimulator. The right hippocampal depth lead was 
pulled back into the posterior hippocampus and medial temporooccipital 
lobe at the time of a right anteromedial temporal lobectomy
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The mean follow-up after MTL resection was 35 months 
(median: 19  months, range: 6-111  months). The median 
reduction in patient-reported seizures at last follow-up 
was 100% (mean: 92%; range: 50%-100%) and the re-
sponder rate (≥50% reduction in disabling seizures) was 
100%. Seventy-one percent of patients (17/24) were free 
of disabling clinical seizures for at least 3  months at the 
most recent follow-up (Table 3); the mean duration of sei-
zure freedom was 14 months (median: 12 months, range: 
3-57  months; Figure 3). Of the patients with more than 
1 year of follow-up (N = 21), 15 patients (71%) were sei-
zure-free during the most recent year, including all 8 pa-
tients with unilateral onsets and 7 of 13 patients (54%) with 
bilateral onsets. At last follow-up, 71% (17/24) were sei-
zure-free for at least 3 months.
Using the CGIS Scores (Table 3), physicians indicated that 
20 of 24 patients (83%) were “very much improved” (14; 58%) 
or “much improved” (6; 25%), three (12.5%) were minimally 
improved, and one (4%) had no change (details in subsections 
below). Five patients (21%) obtained their driver's license.
3.5 | Patients with only unilateral 
MTL seizure onsets recorded with chronic 
ambulatory ICEEG
Nine of the 24 patients (38%) had only unilateral electro-
graphic seizure onsets captured by chronic ambulatory 
ICEEG over an average of 48 months prior to MTL resec-
tion. The median seizure-frequency reduction with brain-re-
sponsive neurostimulation prior to MTL resection was 75% 
(range: 0%-87%). Follow-up after MTL resection ranged 
from 11-67 months. At last follow-up, all nine patients were 
free of disabling clinical seizures, (Figure 3, gray bars). 
Seven of the nine patients (78%) were continuously free of 
disabling clinical seizures after MTL resection, and two of 
the nine (22%) had rare disabling clinical seizures in the first 
year and later became free of disabling clinical seizures (for 
>1 year).
Eight of the nine patients continued to be treated with the 
RNS System after MTL resection. Three of the eight were 
monitored using only leads contralateral to the resection. Five 
of the eight were monitored bilaterally (strip added at the time 
of resection or lead remained in/next to resection); three of 
these patients had an electrographic seizure recorded by the 
RNS System from the temporal lobe contralateral to the re-
section, but none from the side of the resection. Details of the 
lateralization before and after RNS System treatment can be 
found in Table 2.
On the CGIS at most recent follow-up, five of the nine pa-
tients (56%) were classified by their physician as “very much 
improved” and two of the nine (22%) as “much improved.” One 
patient was considered to be “minimally improved” because of 
a worsening in preexisting depression and complaints of chronic 
pain at the craniotomy site (postsurgery). One patient was con-
sidered to have “no change” after MTL resection because of 
worsened short-term memory, worsening of baseline depres-
sion, and recurrent psychogenic nonepileptic seizures requiring 
emergency department or hospital visits. Four of the nine pa-
tients (44%) were able to stop at least one antiseizure medica-
tion. No patient stopped all antiseizure medications. Three of 
the nine patients (33%) obtained a driver's license.
 
Unilateral MTL 
seizures 
by chronic 
ambulatory ICEEG 
[N = 9]
Bilateral MTL 
seizures 
by chronic 
ambulatory 
ICEEG [N = 15]
Total 
[N = 24]
Seizure outcomes
Seizure-free ≥3 mo 9/9 (100%) 8/15 (53%) 71% (17/24)
Seizure-free ≥12 mo 8/8 (100%) 7/13 (54%) 71% (15/21)
Respondersa (≥50% 
reduction)
9/9 (100%) 15/15 (100%) 24/24 (100%)
Nonrespondersa (<50% 
reduction)
0 0 0
Clinician Global Impression Scale Scores
Very much improved 5 9 14
Much Improved 2 4 6
Minimally Improved 1 2 3
No change 1 0 1
Abbreviations: ICEEG, intracranial EEG; MTL, mesial temporal lobe.
aBased on the final 3 mo period of follow-up compared to the 3 mo prior to MTL resection. 
T A B L E  3  Seizure outcomes and 
Clinician Global Impression Scale scores at 
last follow-up
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3.6 | Patients with bilateral MTL 
electrographic seizure onsets with chronic 
ambulatory ICEEG monitoring
Fifteen of the 24 patients (62%) had bilateral electrographic 
seizures on chronic ambulatory ICEEG monitoring over 
6-111 months of follow-up. Nonetheless, 8 of the 15 patients 
(53%) were free of disabling clinical seizures (Figure 3, blue 
bars). In these eight seizure-free patients, the percentage of 
seizures arising from the resected side on chronic ambulatory 
ICEEG ranged from 75%-97% (median 91% [Table 2]). Three 
of the eight seizure-free patients (38%) were free of disabling 
clinical seizures continuously after MTL resection; five sei-
zure-free patients (62%) had rare disabling clinical seizures in 
the first year and then became free of clinical seizures (four of 
five were seizure-free for the final year or longer, and the fifth 
patient was seizure-free for the final 11 months).
All 15 patients in this group continued to be treated with the 
RNS System after MTL resection. Thirteen of the 15 patients 
(87%) continued to be monitored bilaterally (strip added at 
time of resection or lead remained in/next to resection). All 
13 patients had electrographic seizures recorded by the RNS 
System after MTL resection (which may or may not have 
manifested clinically); 10 patients had electrographic seizure 
onsets recorded contralateral to the MTL resection (6 of 10 
were clinically seizure-free), two patients had electrographic 
seizure onsets ipsilateral to MTL resection (both were clini-
cally seizure-free), and one patient had bilateral independent 
electrographic seizure onsets recorded (75% clinical seizure 
reduction). Two patients were monitored only contralateral to 
MTL resection; both had post-MTL resection electrographic 
seizures recorded. One of these patients was free of disabling 
clinical seizures and the other had a 65% reduction in dis-
abling clinical seizures. Details of lateralization before and 
after RNS System treatment can be found in Table 2.
On the CGIS after MTL resection, 9 of these 15 patients 
(60%) were classified as “Very Much Improved,” four (27%) 
were “Much Improved,” and two (13%) were “Minimally 
Improved” (Table 3). One of the “minimally improved” pa-
tients was completely seizure-free since MTL resection but 
had a worsening of baseline depression, requiring multiple 
hospitalizations for suicidal ideation. The second patient with 
minimal improvement had a 50% reduction in clinical seizures. 
Four patients were able to reduce at least one antiseizure med-
ication. No patients discontinued antiseizure medication com-
pletely. Two patients obtained a driver's license.
3.7 | Safety
RNS System related adverse events were captured for all pa-
tients prior to the MTL resection. Three patients (12.5%) had ad-
verse events. Two patients developed an implant-site infection 
(8.3%) and one patient had a scalp dehiscence (4.2%). All three 
events resolved, and none of the neurostimulators or leads were 
explanted permanently. No other adverse events were reported.
Adverse events related to MTL resection occurred in nine 
patients (37.5%). These included worsening in baseline depres-
sion (three patients; 12.5%), worsening of preexisting memory 
complaints (two patients; 8.3%), infection (two patients; 8.3%), 
recurrence of psychogenic seizures (one patient; 4.2%), and 
chronic pain at the craniotomy site (one patient; 4.2%). Of the 
three patients with worsening of depression, two had right MTL 
surgeries and one had left MTL resection; all depressive epi-
sodes were ongoing at data cutoff. The infections in two patients 
resolved. One of the patients delayed reporting a scalp-incision 
site infection due to their distance from the hospital and the in-
fection eventually required removal of the neurostimulator and 
leads. The other patient had a scalp- and craniotomy-site infec-
tion which did not require explant of the neurostimulator and 
leads. Of the two patients with subjectively reported worsening 
of memory, one had a right MTL resection, bilateral MTS, left 
F I G U R E  3  Percent changes in clinical seizure frequency at most 
recent follow-up in patients with unilateral (gray) and bilateral (blue) 
mesial temporal lobe (MTL) electrographic seizures recorded on RNS 
System chronic ambulatory intracranial EEG (ICEEG)
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hemisphere language dominance, and intact left hemisphere 
memory on Wada testing. The memory decline was only pres-
ent postictally after clusters of seizures arising from the left. The 
other patient with subjective memory decline had a left MTL 
resection, left hemisphere language dominance, and bilateral in-
tact memory on Wada testing. Both memory complaints were 
ongoing, although the postictal deficit was infrequent due to 
markedly improved seizure frequency. The adverse events re-
lated to psychogenic seizures and craniotomy site pain were re-
ported to be ongoing at last follow-up.
4 |  DISCUSSION
Chronic ambulatory bilateral MTL ICEEG monitoring with a 
direct brain-responsive neurostimulator identified patients who 
benefitted from a unilateral MTL resection. Based on acute in-
tracranial monitoring and other presurgical data, these patients 
were not initially considered to be appropriate for resective 
surgery. All nine patients whose seizures were determined to 
be unilateral with RNS System chronic ambulatory ICEEG be-
came seizure-free after MTL resection. Even patients with in-
dependent bilateral onsets with a unilateral preponderance had 
substantial benefit, with a median percent seizure reduction of 
100% (range: 50%-100%) and just over half (8/15) becoming 
seizure-free. In all but one patient, surgery was combined with 
continued RNS System treatment. Clinicians rated patients as 
much improved or very much improved in 20 of 24 cases. Five 
patients (21%) obtained their driver's licenses.
Lateralization of an MTL seizure focus relies on a mul-
timodal evaluation that incorporates data from history, neu-
roimaging, neuropsychological testing, and inpatient video 
and scalp or ICEEG recordings over days to weeks. Patients 
whose data are entirely concordant for a unilateral MTL onset 
have a high probability of seizure remission after an MTL re-
section or ablation. However, electrographic, neurocognitive, 
or imaging abnormalities suggestive of abnormalities in both 
temporal lobes reduce the probability of seizure freedom.15
Failed MTL surgeries may be due to bilateral MTL epi-
lepsy that was not identified during preoperative localization 
studies.16 Overall, 27%-42% of patients undergoing MTL 
surgeries do not remit over the first postoperative year,3,15 
and the percentage increases to 48% at 5 years and 53% at 
10 years.17,18 If localization data are not entirely concordant 
for unilateral MTL onsets, then the chance of seizure remis-
sion is reduced. In a series of 27 MTL resection failures, 
Abosch et al17 reported that bilateral temporal lobe onsets, 
bilateral abnormal MRI findings, or both, were a predictor of 
seizure relapse. Jeha, et al19 demonstrated that in 371 patients 
treated with unilateral temporal lobe surgery, seizure freedom 
rate was 73% at 6 months and 58% at 2 years if there were bi-
lateral MRI abnormalities, compared to 88% at 6 months and 
78% at 2 years for those without bilateral MRI abnormalities.
Chronic ambulatory ICEEG monitoring provides electro-
graphic data over months and years that could importantly 
supplement the spatially rich but temporally limited data from 
the EMU. Data from chronic ambulatory ICEEG indicate that 
typical in-patient EEG evaluations, whether scalp or intra-
cranial, could lead to inaccurate conclusions about whether a 
patient has unilateral or bilateral MTL seizures. In a retrospec-
tive study of 82 patients with bilateral MTL seizures treated 
with brain-responsive neurostimulation, about half had only 
unilateral MTL seizures in the first 2 weeks of chronic ambu-
latory ICEEG. Without prolonged monitoring, these patients 
with MTL seizures could have been incorrectly identified as 
having only unilateral onsets. Conversely, some patients who 
have bilateral MTL seizures during in-patient scalp or ICEEG 
may have only unilateral seizures in the real world when on 
their antiseizure medications. This was the case in one study 
of 71 patients with presumed bilateral MTL onset by in-pa-
tient video-EEG monitoring with scalp (52%) or scalp and 
intracranial electrodes (48%). Thirteen percent had only uni-
lateral electrographic seizures over a mean 42 months of RNS 
System chronic ambulatory ICEEG monitoring.5
Lateralization of MTL seizures by inpatient ICEEG was 
misleading in some of the patients in this study. Twelve of the 
24 patients were monitored with inpatient ICEEG and the in-
patient lateralization was misleading in 7 of 12 (58%, Table 2). 
Three patients had bilateral MTL seizures during short-term 
inpatient ICEEG but only unilateral seizures by chronic ambu-
latory ICEEG, two patients had only unilateral MTL seizures 
with short-term inpatient ICEEG but had bilateral seizures 
by chronic ambulatory ICEEG, and the preponderance of left 
compared to right MTL seizures based on short-term inpatient 
ICEEG was incorrect in two patients. These data confirm the 
danger of relying on lateralizing information based on short-
term inpatient intracranial EEG.
There are several reasons for possible discrepancies 
between inpatient EEG monitoring results (scalp and in-
tracranial) and chronic ambulatory ICEEG. These include 
undersampling due to the short time window for inpatient 
recordings, as already discussed, and likely the most import-
ant factor. Other reasons could be that atypical seizures are 
triggered by the stress of the inpatient environment (includ-
ing sleep disruption, medication changes, and sometimes 
anesthesia, analgesics, and steroids), that atypical seizures 
arise because of inpatient medication withdrawal, or because 
either medications or brain-responsive neurostimulation 
suppresses seizures in one MTL, but not the other.
There are other reports of patients treated with MTL surgeries 
based on information from chronic ambulatory ICEEG monitor-
ing. In some cases, MTL resection was intended to result in sei-
zure remission and in others, significant palliation.20,21 DiLorenzo, 
et al described four patients who were not considered surgery 
candidates because seizures arose from more than one focus. 
Based on chronic ambulatory ICEEG monitoring data from the 
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brain-responsive neurostimulator, these patients underwent a re-
sective procedure and were seizure-free.20 Enatsu et al described a 
patient who was not considered a surgical candidate due to bilateral 
MTL onsets. Chronic ambulatory ICEEG recordings from bilateral 
hippocampal depth leads revealed a preponderance of right-sided 
electrographic seizure onsets. The patient subsequently underwent 
a right MTL resection, continued to be treated with brain-respon-
sive neurostimulation, and became seizure free.21
The majority of patients with seizures of MTL onsets 
benefit substantially from brain-responsive neurostimulation, 
whether treated unilaterally or bilaterally.22,23 Patients in the 
RNS System clinical trials who had MTL onsets (N = 111) 
were selected for treatment with brain-responsive neurostim-
ulation because seizures were bilateral (72%) or unilateral 
(28%) and there was concern that a resection would cause 
memory or language deficits, because the patient had already 
had a MTL resection, or because the patient chose not to have 
a MTL resection. Over 9 years of prospective follow-up, the 
clinical response for patients with unilateral or bilateral MTL 
onsets improved over time, from 50% median reduction in 
seizure frequency at 2 years to 73% at 9 years.22,23
In some patients, combining a resective or ablative proce-
dure with brain-responsive neurostimulation can be effective. 
The majority of patients (71%) in this cohort became free of 
disabling clinical seizures after MTL resection; 23 of 24 (96%) 
continued to be monitored and treated with the brain-respon-
sive neurostimulator, either contralateral to the resection (5/24; 
21%), or bilaterally (18/24; 75%). All seven patients who did 
not achieve seizure freedom after MTL resection had bilat-
eral electrographic seizures recorded by chronic ambulatory 
ICEEG, and surgery was intended to provide significant pallia-
tion. These seven patients continued to be treated with brain-re-
sponsive neurostimulation. As hoped, all of these patients had 
subjective and objective improvements in seizure burden, as-
sessed by the CGIS and change in seizure frequency (all >50% 
seizure reduction). The infrequent adverse memory and mood 
events seen in this cohort are similar to those seen in MTL sur-
geries in general, reminding us that all patients should be care-
fully screened and counseled about these possibilities.
The efficacy of brain-responsive neurostimulation in-
creases over time. Based on the experience in the RNS System 
clinical trials and in this series, 24 months seems an appropri-
ate period of time to assess the response to brain-responsive 
neurostimulation and to draw a confident conclusion about 
lateralization of stimulation-resistant and medication-resistant 
seizures. At that point, a decision can be made regarding con-
tinued treatment with brain-responsive neurostimulation alone 
or in combination with a resective or ablative procedure.
Data from the RNS System complement but cannot replace 
inpatient EEG monitoring. The RNS System chronic ambula-
tory ICEEG data cannot determine whether an electrographic 
seizure is also a clinically evident seizure. In addition, there are 
limitations for RNS System data sampling and storage. First, 
chronic ambulatory ICEEG sampling is limited to eight elec-
trodes. Second, the chronic ambulatory ICEEG storage capac-
ity of the RNS System is limited. Memory is freed up when 
patients upload daily neurostimulator data to their home-use 
remote monitor. Although the RNS System is programmed 
to prioritize storage of electrographic seizures, it is possible 
that records of electrographic seizures are overwritten if there 
are more events than can be stored between patient uploads. 
Another potential data storage confounder is that the RNS 
System detection settings are modified throughout the years 
of treatment and this will influence the types of events that 
are detected and stored. However, in typical practice, detection 
settings are stable after the first year of treatment.
In conclusion, direct brain-responsive neurostimulation is 
demonstrated to be safe and effective in patients with med-
ically intractable epilepsy, including those with unilateral 
and bilateral MTL epilepsy.22,23 For many patients, direct 
brain-responsive neurostimulation will achieve the therapeu-
tic goal. However, for some MTL patients, resective or ab-
lative procedures can provide additional benefit. In patients 
with MTL epilepsy, if a confident lateralization cannot be 
achieved with standard localization techniques alone (as is 
often the case if there is any evidence of bitemporal epilepsy), 
chronic ambulatory ICEEG monitoring can establish whether 
a patient has unilateral or bilateral onsets, the preponderance 
of seizures in those with bilateral onsets, and who is likely, 
or unlikely, to benefit from a MTL resection. In carefully se-
lected patients with MTL epilepsy, combining resective or 
ablative MTL procedures with direct brain-responsive neuro-
stimulation may achieve excellent seizure outcomes.
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